Effect of Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) on Weight Loss Following Bariatric Treatment.
Caroline Kaercher KramerMatthew RetnakaranLuciana V VianaPublished in: The Journal of clinical endocrinology and metabolism (2024)
Our findings suggest that the use of liraglutide and semaglutide in patients who previously underwent MBS can promote significant weight reduction with an acceptable safety profile.
Keyphrases
- weight loss
- bariatric surgery
- roux en y gastric bypass
- gastric bypass
- rheumatoid arthritis
- weight gain
- body mass index
- glycemic control
- physical activity
- disease activity
- ankylosing spondylitis
- combination therapy
- obese patients
- type diabetes
- metabolic syndrome
- systemic lupus erythematosus
- systemic sclerosis
- skeletal muscle